{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cathelicidin- BF", "MRSA", "antibiotic resistance", "antimicrobial peptides", "cytotoxic activity"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29392557", "DateCompleted": {"Year": "2018", "Month": "08", "Day": "01"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "02", "Day": "02"}], "Language": ["eng"], "ELocationID": ["10.1007/s12275-018-7444-5"], "Journal": {"ISSN": "1976-3794", "JournalIssue": {"Volume": "56", "Issue": "2", "PubDate": {"Year": "2018", "Month": "Feb"}}, "Title": "Journal of microbiology (Seoul, Korea)", "ISOAbbreviation": "J Microbiol"}, "ArticleTitle": "The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.", "Pagination": {"StartPage": "128", "EndPage": "137", "MedlinePgn": "128-137"}, "Abstract": {"AbstractText": ["Cathelicidins are a family of antimicrobial peptides which exhibit broad antimicrobial activities against antibiotic-resistant bacteria. Considering the progressive antibiotic resistance, cathelicidin is a candidate for use as an alternative approach to treat and overcome the challenge of antimicrobial resistance. Cathelicidin-BF (Cath-BF) is a short antimicrobial peptide, which was originally extracted from the venom of Bungarus fasciatus. Recent studies have reported that Cath-BF and some related derivatives exert strong antimicrobial and weak hemolytic properties. This study investigates the bactericidal and cytotoxic effects of Cath-BF and its analogs (Cath-A and Cath-B). Cath-A and Cath-B were designed to increase their net positive charge, to have more activity against methicillin resistant S. aureus (MRSA). The results of this study show that Cath-A, with a +17-net charge, has the most noteworthy antimicrobial activity against MRSA strains, with minimum inhibitory concentration (MIC) ranging between 32-128 \u03bcg/ml. The bacterial kinetic analysis by 1 \u00d7 MIC concentration of each peptide shows that Cath-A neutralizes the clinical MRSA isolate for 60 min. The present data support the notion that increasing the positive net charge of antimicrobial peptides can increase their potential antimicrobial activity. Cath-A also displayed the weakest cytotoxicity effect against human umbilical vein endothelial and H9c2 rat cardiomyoblast cell lines. Analysis of the hemolytic activity reveals that all three peptides exhibit minor hemolytic activity against human erythrocytes at concentrations up to 250 \u03bcg/ml. Altogether, these results suggest that Cath-A and Cath-B are competent candidates as novel antimicrobial compounds against MRSA and possibly other multidrug resistant bacteria."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pediatric Infections Research Center (PIRC), Research Institute for Children health, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Tajbakhsh", "ForeName": "Mercedeh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pediatric Infections Research Center (PIRC), Research Institute for Children health, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Karimi", "ForeName": "Abdollah", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute of Molecular Medicine and Pathobiochemistry, Krasnoyarsk State Medical University, Krasnoyarsk, Russia."}], "LastName": "Tohidpour", "ForeName": "Abolghasem", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran."}, {"Identifier": [], "Affiliation": "Biotechnology and Medicinal Plants Research Center, Ilam University of Medical Sciences, Ilam, Iran."}], "LastName": "Abbasi", "ForeName": "Naser", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pediatric Infections Research Center (PIRC), Research Institute for Children health, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Fallah", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. m_akhavan@sbmu.ac.ir."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, Medical School, Iran University of Medical Sciences, Tehran, Iran. m_akhavan@sbmu.ac.ir."}], "LastName": "Akhavan", "ForeName": "Maziar Mohammad", "Initials": "MM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Korea (South)", "MedlineTA": "J Microbiol", "NlmUniqueID": "9703165", "ISSNLinking": "1225-8873"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antimicrobial Cationic Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Cathelicidins"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Venoms"}, {"RegistryNumber": "0", "NameOfSubstance": "cathelicidin BF, Bungarus fasciatus"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amino Acid Sequence"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antimicrobial Cationic Peptides"}, {"QualifierName": ["metabolism"], "DescriptorName": "Bungarus"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cathelicidins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Microbial"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Multiple, Bacterial"}, {"QualifierName": [], "DescriptorName": "Hemolysis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Iran"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": ["drug effects"], "DescriptorName": "Methicillin-Resistant Staphylococcus aureus"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Peptides"}, {"QualifierName": [], "DescriptorName": "Protein Conformation"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["chemistry"], "DescriptorName": "Venoms"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Peptides. 2011 Dec;32(12):2497-503", "ArticleIdList": ["22008732"]}, {"Citation": "Peptides. 2008 Oct;29(10):1685-91", "ArticleIdList": ["18620012"]}, {"Citation": "Front Microbiol. 2013 Oct 01;4:294", "ArticleIdList": ["24101917"]}, {"Citation": "PLoS One. 2016 May 12;11(5):e0155529", "ArticleIdList": ["27171373"]}, {"Citation": "Gene. 1990 Sep 28;94(1):137-8", "ArticleIdList": ["2227446"]}, {"Citation": "Lancet Infect Dis. 2013 Dec;13(12):1057-98", "ArticleIdList": ["24252483"]}, {"Citation": "Antibiotics (Basel). 2014 Oct 13;3(4):461-92", "ArticleIdList": ["25419466"]}, {"Citation": "Annu Rev Pharmacol Toxicol. 2012;52:337-60", "ArticleIdList": ["22235859"]}, {"Citation": "Medicina (Kaunas). 2011;47(3):137-46", "ArticleIdList": ["21822035"]}, {"Citation": "Br J Biomed Sci. 2015;72(2):47-51", "ArticleIdList": ["26126318"]}, {"Citation": "Peptides. 2011 Jun;32(6):1131-8", "ArticleIdList": ["21515321"]}, {"Citation": "Health Commun. 2015 ;30(3):309-14", "ArticleIdList": ["25121990"]}, {"Citation": "Biomed Res Int. 2014;2014:867381", "ArticleIdList": ["25243191"]}, {"Citation": "PLoS One. 2008 Sep 16;3(9):e3217", "ArticleIdList": ["18795096"]}, {"Citation": "Nat Protoc. 2008;3(2):163-75", "ArticleIdList": ["18274517"]}, {"Citation": "Nature. 2002 Jan 24;415(6870):389-95", "ArticleIdList": ["11807545"]}, {"Citation": "Methods Mol Biol. 2014;1088:159-70", "ArticleIdList": ["24146403"]}, {"Citation": "Clin Microbiol Rev. 2015 Jul;28(3):603-61", "ArticleIdList": ["26016486"]}, {"Citation": "PLoS One. 2014 Apr 22;9(4):e92760", "ArticleIdList": ["24755631"]}, {"Citation": "Phytother Res. 2014 Sep;28(9):1301-7", "ArticleIdList": ["25201753"]}, {"Citation": "Int J Antimicrob Agents. 2013 Jun;42 Suppl:S25-8", "ArticleIdList": ["23684003"]}, {"Citation": "FEMS Microbiol Lett. 2002 Jan 10;206(2):143-9", "ArticleIdList": ["11814654"]}, {"Citation": "Eur J Biochem. 2003 May;270(10):2207-17", "ArticleIdList": ["12752440"]}, {"Citation": "J Biol Chem. 2005 Apr 1;280(13):12316-29", "ArticleIdList": ["15677462"]}, {"Citation": "P T. 2015 Apr;40(4):277-83", "ArticleIdList": ["25859123"]}, {"Citation": "Pharmaceuticals (Basel). 2013 Nov 28;6(12):1543-75", "ArticleIdList": ["24287494"]}, {"Citation": "Biochim Biophys Acta. 1999 Dec 15;1462(1-2):71-87", "ArticleIdList": ["10590303"]}, {"Citation": "Bioinformatics. 2008 Sep 15;24(18):2101-2", "ArticleIdList": ["18662927"]}, {"Citation": "Curr Issues Mol Biol. 2005 Jul;7(2):179-96", "ArticleIdList": ["16053249"]}, {"Citation": "Mol Biol Rep. 2012 Dec;39(12):10957-70", "ArticleIdList": ["23065264"]}, {"Citation": "Peptides. 2003 Nov;24(11):1681-91", "ArticleIdList": ["15019199"]}, {"Citation": "Biochim Biophys Acta. 2013 Dec;1833(12 ):3460-3470", "ArticleIdList": ["23850759"]}, {"Citation": "PLoS One. 2011;6(7):e22120", "ArticleIdList": ["21789223"]}, {"Citation": "PLoS One. 2012;7(8):e39373", "ArticleIdList": ["22879874"]}, {"Citation": "Protein Pept Lett. 2017;24(2):174-180", "ArticleIdList": ["27897110"]}, {"Citation": "Int J Mol Med. 2013 Feb;31(2):471-6", "ArticleIdList": ["23254439"]}, {"Citation": "JAMA. 2014 May 14;311(18):1853-4", "ArticleIdList": ["24652442"]}, {"Citation": "Eur J Pharmacol. 2013 May 5;707(1-3):1-10", "ArticleIdList": ["23541725"]}, {"Citation": "FEBS J. 2011 May;278(9):1573-84", "ArticleIdList": ["21375690"]}, {"Citation": "Nat Chem Biol. 2013 Dec;9(12):761-8", "ArticleIdList": ["24231617"]}, {"Citation": "Peptides. 2010 Aug;31(8):1488-93", "ArticleIdList": ["20576537"]}, {"Citation": "Peptides. 2009 Feb;30(2):283-90", "ArticleIdList": ["19007829"]}, {"Citation": "Dev Comp Immunol. 2011 Mar;35(3):314-22", "ArticleIdList": ["20955730"]}]}], "History": [{"Year": "2017", "Month": "10", "Day": "18"}, {"Year": "2017", "Month": "12", "Day": "11"}, {"Year": "2017", "Month": "11", "Day": "28"}, {"Year": "2018", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "2", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29392557", "10.1007/s12275-018-7444-5", "10.1007/s12275-018-7444-5"]}}]}